ACTA1 and Hepatic fibrosis: Histologically, reversine significantly decreased the expression of the liver fibrosis markers α‐SMA and Desmin, and decreased the expression of biliary protein markers CK7, CK19, and EpCAM, demonstrating reversine's ability to attenuate DR and fibrogenesis.